A practical approach to reporting treatment abandonment in pediatric chronic conditions

Meaghann S Weaver1, Ramandeep S Arora, Scott C Howard

  • 1St Jude Children's Research Hospital, Memphis, Tennessee.

Pediatric Blood & Cancer
|January 15, 2015
PubMed

Insights

Treatment abandonment in children with chronic conditions leads to treatment failure. Clear definitions and categorization of incomplete treatment are crucial for accurate outcomes in pediatric oncology.

Area of Science:

  • Pediatric Oncology
  • Global Health
  • Health Outcomes Research

Background:

  • Treatment abandonment is a major cause of treatment failure in pediatric chronic conditions, especially cancer, in low- and middle-income countries.
  • Incomplete treatment forms like nonadherence and loss to follow-up are often conflated with abandonment, impacting reported outcomes.
  • Ambiguous definitions of incomplete treatment hinder accurate assessment and comparison of treatment success.

Purpose of the Study:

  • To propose a practical approach for categorizing forms of incomplete treatment in pediatric chronic conditions.
  • To establish distinct semantic categories with illustrative case examples for clarity.
  • To develop a adaptable algorithm for disease- and context-specific needs in analyzing treatment completion.

Main Methods:

  • Literature review and conceptual analysis to define and differentiate forms of incomplete treatment.
  • Development of a categorization framework with clear semantic distinctions.
  • Creation of case examples to illustrate each category.
  • Design of a flexible algorithm for classifying treatment completion status.

Main Results:

  • Identified and defined distinct categories of incomplete treatment, including abandonment, nonadherence, and loss to follow-up.
  • Provided case examples to clarify the application of these categories.
  • Outlined a practical algorithm to aid in consistent classification across different studies and contexts.

Conclusions:

  • Standardized definitions and categorization of incomplete treatment are essential for improving pediatric cancer care outcomes.
  • The proposed framework and algorithm can enhance the accuracy of reported outcomes and facilitate cross-study comparisons.
  • Implementing these tools can support better disease management and targeted interventions for children with chronic conditions globally.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
886
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
371
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
943
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
691
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.4K